Dimension Therapeutics, Inc. (DMTX) is a publicly traded company in the Unknown sector. Across all available filings, 6 corporate insiders have executed 17 transactions totaling $17.7M, demonstrating a bullish sentiment with $17.6M in net insider flow. The most recent transaction on Nov 7, 2017 involved a transaction of 278,035 shares valued at $0.
No significant insider buying has been recorded for DMTX in the recent period.
No significant insider selling has been recorded for DMTX in the recent period.
Based on recent SEC filings, insider sentiment for DMTX is bullish with an Insider Alignment Score of 100/100 and a net flow of $17.6M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Dimension Therapeutics, Inc. (DMTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 6 insiders are actively trading DMTX stock, having executed 17 transactions in the past 90 days. The most active insider is Llc Fmr (Executive), who has made 6 transactions totaling $29.4M.
Get notified when executives and directors at DMTX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 7, 2017 | C. Wadsworth Samuel | Executive | Disposition | 278,035 | $N/A | $0 | |
| Nov 7, 2017 | Fmr Llc | Executive | Tender | 3,838,249 | $6.00 | $23.0M | Large |
| Nov 7, 2017 | Fmr Llc | Executive | Tender | 5,057 | $6.00 | $30.3K | |
| Nov 7, 2017 | Fmr Llc | Executive | Tender | 1,050,016 | $6.00 | $6.3M | Large |
| Jun 7, 2016 | Reed Clark K. | Executive | Option Exercise | 5,000 | $0.38 | $1.9K | |
| Jun 7, 2016 | Reed Clark K. | Executive | Sale | 5,000 | $10.00 | $50.0K | |
| May 2, 2016 | Fmr Llc | Executive | Other | 2,106,784 | $N/A | $0 | |
| Oct 27, 2015 | Fmr Llc | Executive | Conversion | 1,628,914 | $N/A | $0 | |
| Oct 27, 2015 | Fmr Llc | Executive | Conversion | 5,131,713 | $N/A | $0 | |
| Oct 27, 2015 | Dybbs Michael | Executive | Conversion | 1,097,745 | $N/A | $0 | |
| Oct 27, 2015 | Dybbs Michael | Executive | Purchase | 961,538 | $13.00 | $12.5M | Large |
| Oct 27, 2015 | Gupta Rishi | Executive | Conversion | 1,947,613 | $N/A | $0 | |
| Oct 27, 2015 | Gupta Rishi | Executive | Purchase | 200,000 | $13.00 | $2.6M | Large |
| Oct 27, 2015 | Gupta Rishi | Executive | Conversion | 3,250,085 | $N/A | $0 | |
| Oct 27, 2015 | D. Isaly Samuel | Executive | Conversion | 3,250,085 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Tender(U) | 3 | $29.4M | 62.3% |
Purchase(P) | 3 | $17.7M | 37.6% |
Sale(S) | 1 | $50.0K | 0.1% |
Exercise(M) | 1 | $1.9K | 0.0% |
Disposition(D) | 1 | $0 | 0.0% |
Other(J) | 1 | $0 | 0.0% |
Conversion(C) | 7 | $0 | 0.0% |
Insiders at Dimension Therapeutics, Inc. are accumulating shares at an accelerated pace. With 6 insiders making 17 transactions totaling $17.7M in purchases versus $50.0K in sales, the net buying activity of $17.6M signals strong executive confidence. Llc Fmr (Executive) leads the buying activity with $29.4M in transactions across all time.